REC-4881

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC MutationNCT06005974RXRXPhase 2Terminated2025-02-24Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.